IP Library Granted Patent US 11,125,742
Granted Patent B2
US 11,125,742 · App. 14/129,510 · Granted Sep 21, 2021

Non-specific reaction inhibitor, method for inhibiting non-specific reaction, and kit

Inventors: Yoshikazu Okamura (Tokyo, JP); Shigeru Tashiro (Tokyo, JP)
Assignee: LSI MEDIENCE CORPORATION
G01N33/5306C07D207/416
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,125,742
App. No.
14/129,510
Granted
Sep 21, 2021
Kind
B2
Abstract

Provided is a non-specific reaction inhibitor for achieving the accurate detection and quantitation of a trace component (a target substance) contained in a sample, in an immunoassay, by simply and effectively inhibiting a non-specific reaction associated with the measurement. The non-specific reaction inhibitor comprises a substance of the formula I: wherein R 1 and R 2 together form a double bond between carbons, to which they are respectively bonded directly, or R 1 is a hydrogen atom and R 2 is a group formed by removing H from an SH-group-containing compound, B is a support, and L is a spacer arm portion.

Claims (14)

1. An immunological measurement method, said method comprising:

providing (1) a sample containing a target substance and a non-specific reaction substance capable of binding directly to a maleimide group, (2) a non-specific reaction inhibitor of the formula I:

wherein R 1 and R 2 together form a double bond between carbons to which they are respectively bonded directly, B is a support that is inactive in an assay system, and L is a spacer arm portion having a length of 4 to 20 Å, and (3) a reagent prepared by immobilizing an antibody or an antigen specific for the target substance on a support, or labeling an antibody or an antigen specific for the target substance, by a maleimide method using a cross-linking agent containing a maleimide group;

treating the sample (1) with the non-specific reaction inhibitor (2), to absorb a non-specific reaction activity of the non-specific reaction substance by the non-specific reaction inhibitor (2), said non-specific reaction substance being contained in the sample (1);

reacting the treated sample with the reagent (3) to form an immunological complex; and

analyzing the immunological complex in the immunological measurement method by accounting for the non-specific reaction substance.

2. The immunological measurement method according to claim 1 , wherein the immunological measurement method is a latex agglutination optical measurement method, an enzyme immunoassay, a nephelometric immunoassay, an enzyme-linked immunosorbent assay, a fluorescence immunoassay, or a radioimmunoassay.

3. An immunological measurement method, said method comprising:

providing (1) a sample containing a target substance and a non-specific reaction substance capable of binding directly to a maleimide group, (2) a non-specific reaction inhibitor of the formula I:

wherein R 1 and R 2 together form a double bond between carbons to which they are respectively bonded directly, B is a support that is inactive in an assay system, and L is a spacer arm portion having a length of 4 to 20 Å, and (3) a reagent prepared by immobilizing an antibody or an antigen specific for the target substance on a support, or labeling an antibody or an antigen specific for the target substance, by a maleimide method using a cross-linking agent containing a maleimide group;

reacting the sample (1) with the reagent (3) in the presence of the non-specific reaction inhibitor (2) to form an immunological complex, while absorbing a non-specific reaction activity of the non-specific reaction substance by the non-specific reaction inhibitor (2), said non-specific reaction substance being contained in the sample (1); and

analyzing the immunological complex in the immunological measurement method by accounting for the non-specific reaction substance.

4. The immunological measurement method according to claim 1 , wherein the immunological measurement method is a measurement by a sandwich method, and one or more steps of immunological reactions specific for the target substance contained in the sample is carried out in the presence of the non-specific reaction inhibitor (2).

5. The immunological measurement method according to claim 3 , wherein the immunological measurement method is a latex agglutination optical measurement method, an enzyme immunoassay, a nephelometric immunoassay, an enzyme-linked immunosorbent assay, a fluorescence immunoassay, or a radioimmunoassay.

Assignments (4)
CHANGE OF ADDRESS Recorded Feb 25, 2024
From: LSI MEDIENCE CORPORATION
To: LSI MEDIENCE CORPORATION
Reel/Frame 066674/0958 →
COMPANY SPLIT Recorded Feb 25, 2024
From: LSI MEDIENCE CORPORATION
To: PHC CORPORATION
Reel/Frame 066675/0001 →
CHANGE OF NAME Recorded Feb 5, 2015
From: MITSUBISHI CHEMICAL MEDIENCE CORPORATION
To: LSI MEDIENCE CORPORATION
Reel/Frame 034916/0083 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2014
From: OKAMURA, YOSHIKAZU; TASHIRO, SHIGERU
To: MITSUBISHI CHEMICAL MEDIENCE CORPORATION
Reel/Frame 031973/0551 →
Priority Claims (1)
JP JP2011-144464 · Jun 29, 2011 · national
Continuity (1)
Related Publication 20140193842A1 · Jul 10, 2014